Blistex Odor Eaters Medicated Foot

Description

NDC 10157-3101-1. Odor-Eaters® is a medicated foot powder formulated with 1% w/w menthol as an external analgesic. This product contains three advanced odor and wetness fighters, effectively controlling odor and wetness while providing relief from itching and irritation. It is designed for all-day effectiveness and is guaranteed to stop odor. The product is available in a net weight of 5 oz. (142 g).

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with minor skin irritations. It is intended for use in patients experiencing such symptoms due to various non-serious dermatological conditions.

Dosage and Administration

Adults and children aged 2 years and older are instructed to apply the product to the affected area no more than 3 to 4 times daily. For children under 2 years of age, it is recommended to consult a physician prior to use.

Prior to application, it is essential to thoroughly wash and dry the feet. The powder should be sprinkled liberally over the feet, ensuring coverage between the toes and on the bottoms of the feet. For optimal results, the application should occur up to 3 or 4 times daily. Additionally, to enhance freshness, it is advisable to sprinkle the powder inside shoes and/or socks.

Contraindications

There are no specific contraindications identified for this product. However, it is advised to discontinue use and consult a physician if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, contact with the eyes should be avoided to prevent irritation or injury.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to avoid contact with the eyes during application. In the event of worsening conditions or if symptoms persist beyond 7 days, it is imperative to discontinue use and consult a physician. Additionally, if symptoms resolve and then recur within a few days, the patient should also seek medical advice.

It is crucial to keep this product out of reach of children. In cases of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients should be aware that this product is for external use only. It is important to avoid contact with the eyes during application.

In clinical practice, if the condition worsens or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, patients are advised to discontinue use of the product and consult a physician.

Additionally, this product should be kept out of reach of children. In the event that the product is swallowed, it is crucial to seek medical help or contact a Poison Control Center immediately.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Blistex Odor Eaters Medicated Foot (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a physician prior to use. For children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of Blistex Odor Eaters Medicated Foot Powder during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in pregnant patients, as the potential effects on fetal outcomes are not established. Women of childbearing potential should be advised to consult their healthcare provider before using this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a physician if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. It is important for patients to understand the significance of these signs and to take appropriate action.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes while using this product, as this could lead to irritation or other adverse effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed when not in use to maintain its integrity. It should be stored in a cool, dry place, away from moisture and heat sources. Freezing is not permitted, as it may compromise the product's quality. Additionally, any unused portion should be discarded after opening, adhering to the specified time frame for safe use.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years of age, it is advised to consult a physician prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Blistex Odor Eaters Medicated Foot, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)